Mario Naranjo-Tovar

The PVD-B65 score fills a longstanding gap in pulmonary vascular medicine. Great work by @GayenShameek @ParthRali @TempleLung @TemplePCCM @HealioPulm @ATS_PC

Temple Lung Center continues to lead in lung care & transplantation. In 2024, we surpassed national benchmarks with a 90%+ survival rate in lung transplants and offer 50+ clinical trials for breakthrough therapies. Learn more: bit.ly/3YfBrTy

Excited to share our novel 1-year mortality risk score in patients specifically w/ chronic lung disease and #pulmonaryhypertension from the @TempleLung #PVD group! doi.org/10.1186/s12890… @JayyyyDr @mbittner91 @MarioNaranjoMD @ParthRali @TemplePCCM @BioMedCentral @RespiratoryBMC

@ParthRali @TempleHealth @TemplePCCM @GayenShameek We’re working hard to grow and advance our program with an amazing team of colleagues and friends. Striving to make a bigger impact every day!! @ParthRali @GayenShameek @TempleLung

@TempleHealth We had Great time showcasing our work for Temple Lung Pulmonary Vascular Disease in terms of scientific research, presentation and bringing more clinical trials back home!! @TemplePCCM #CHEST2024 thank you for all wonderful opportunities!! @GayenShameek @MarioNaranjoMD

The Temple Lung Center team had an incredible time at #CHEST2024! Grateful to all who stopped by our booth and joined our networking reception. Special thank you to Dr. @ParthRali and Dr. Gerard Criner for their groundbreaking presentations on PE management, COPD, and more.

@ParthRali @TemplePCCM @GayenShameek @wm_oldham Let’s go!!

@TemplePCCM @GayenShameek @MarioNaranjoMD let’s do this ! @wm_oldham thank you for sharing

@TemplePCCM Amazing group!! Welcome!!

Thrilled to announce our incoming fellowship class this July! #match2023

On #WorldLungDay we reflect on the global impact of chronic respiratory diseases, and unite to promote better lung health for all. We remain committed to expanding access to preventative services and treatment–and advancing lung health through research, advocacy & education.

Temple University Hospital once again leads the nation, performing more lung transplants than any other center in 2022. With the dedication of our transplant team, we're able to perform transplants for some of the most complex cases, with leading outcomes: bit.ly/45HWXlg

@TemplePCCM @DhananiZehra @mbittner91 Rockstars!!

This week at Jeanes…two of our second year fellows in two different types of difficult experiences- @DhananiZehra in an emergent intubation in the ICU and @mbittner91 interpreting an old school plain film…on actual film! #icudiaries #medtwitter #pccm

Do we need to reassess AVR? Is AVR response at follow‐up, with a possible survival advantage, related to long‐term PAH therapy affecting pulmonary vasomotor response and/or vascular remodeling? Exciting future ahead!!

AVR was as high as 15% in prevalent non-IPAH patients! A less stringent AVR definition may prove to be a useful indicator for a subgroup of patients with more favorable outcomes in response to PAH therapy.

What do we know about AVR in non-IPAH patients? Can it change over time? Sharing our recent study from the PVDOMICS cohort @ATS_PC @PVRI @PulmCirc @JHUPCCMFellows @HopkinsMedicine @TemplePCCM @TempleLung @TempleHealth dx.doi.org/10.1002/pul2.1…

@ParthRali @TemplePCCM @gordon_matt @kvs10231 @MaElenaVS @ParthRali lol you are right!! we should rename it to #ThePulmonologistVentricule.. looking forward to meeting you too !!

@MarioNaranjoMD @TempleLung @TempleHealth @TemplePCCM welcome to Temple Family, looking forward to see you!! and RV lovers club…lol… RV is People’s (but in my humble opinion Pulmonologist Ventricle, is that right?)… @gordon_matt @kvs10231 @MaElenaVS @TemplePCCM

Excited to join the amazing faculty, fellows, and staff at Temple University - Department of Thoracic Medicine & Surgery. Looking forward to working, collaborating, and learning from you all @TempleLung @TempleHealth @TemplePCCM

Excellent talk by @SteveMathaiMD addressing a very important topic “Current Outcome Measures in PH” @HopkinsPCCM @JHUPCCMFellows @ATS_PC @atscommunity

Great mentors!! Great PH team!! @JHUPCCMFellows @HopkinsPCCM @atscommunity @ATS_PC @TijanaTuhy @RDamicoJHHPH @phassou1

Is there anything better than a selfie with our best & brightest #NewFacultyBootcamp #ATS2023 #FutureIsBright Yes 👇🏼

Today is #WorldPHDay2023! Now through May 31, join us in raising #pulmonaryhypertension awareness; advocating for access to #PH diagnosis, treatment and care; and celebrating the lives of people with PH. Learn how you can get involved. ow.ly/TiLo50NRUVe.

Today is #WorldPHDay 2023! We hope to raise awareness for #PulmonaryHypertension continue working on #research and in the clinic to improve the lives of our patients living with #PH! @PHAssociation @PVRI @3CPRCouncil @CHESTPulmCardio @ErsPvd @atscommunity

@RyanTedfordMD @NEJM @Brian_Houston12 Amazing review!! It was a joy to read it @RyanTedfordMD

Happy to share our #ThePeoplesVentricle review out today in @NEJM. We hope this is approachable and useful for all physicians, not just RV experts. Very appreciative of the collaboration with @Brian_Houston12 & #EvanBrittain. @MUSC_Cardiology @MUSChealth nejm.org/doi/full/10.10…